Metropolis Healthcare Limited announced the outcome of its Board Meeting held on February 04, 2026. The Board approved the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. In a significant development, the Board approved and recommended a bonus issue of equity shares in the proportion of 3:1, meaning three fully paid-up equity shares of face value ₹2 each for every one equity share held, subject to necessary approvals. The record date for this bonus issue will be announced later. The company also approved the execution of a Business Transfer Agreement (BTA) for the sale of its External Quality Assessment Services Business (EQAS Division) to its wholly-owned subsidiary, Metropolis Quality Solutions Private Limited (MQSPL), via a slump sale. The consideration for this sale is up to ₹1.25 crore, to be discharged in cash and/or equity shares of MQSPL. The transaction is expected to be completed within six months, subject to conditions precedent and regulatory approvals. The Board meeting commenced at 11:15 a.m. (IST) and concluded at 03:40 p.m. (IST).
